- PHYSOSTIGMINE
- Physostigmine methiodide
- PHYSOSTIGMINE SALICYLATE (1:1)
- Physostigmine sulfate
- 57648-21-21-Butanone,4-[4-(2,3-dihydro-2-thioxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-(4-fluorophenyl)-
- 5764-85-2Benzenepropanoic acid, b-hydroxy-, ethyl ester
- 57648-76-71H-Imidazole,1-(4,5-dimethyl-2-oxido-1,3,2-dioxaphosphol-2-yl)-
- 57649-87-3sodium; ethenyl acetate; prop-2-enoate
- 57650-78-91-(4-PHENOXYPHENOXY)-2-PROPANOL
- 57653-26-6Urea,N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)-
- 57653-35-7CIS-ZHPROME
- 57653-85-7Dibenzo[b,e][1,4]dioxin,1,2,3,6,7,8-hexachloro-
- 5765-44-6Isoxazole, 5-methyl-
- 57654-83-8Nitric-15N acid,potassium salt (1:1)
Hot Products
- 57-67-0Sulfaguanidine
- 57671-19-91,8-DIAZABICYCLO[5.4.0]UNDEC-7-ENE, COMPOUND WITH PHENOL (1:1)
- 57743-63-22-(2-HYDROXY-4-METHYL-3-CYCLOHEXENYL)PROPIONICACIDGAMMA-LACTONE
- 577-59-32-Nitroacetophenone
- 577705-90-9
- 57773-65-6Deslorelin
- 577953-88-9Montelukast Dicyclohexylamine Salt
- 577954-20-27-Amino-4-hydroxy-8-[[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-2-naphthalenesulfonic acid, potassium sodium salt coupled with diazotized 2-[(4-amino-5-methoxy-2-methylphenyl)sulfonyl]ethyl hydrogen sulfate
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
PHYSOSTIGMINE SALICYLATE (1:1) |
EINECS | 200-343-8 |
| CAS No. | 57-64-7 | Density | g/cm3 |
| PSA | 102.34000 | LogP | 3.25810 |
| Solubility | Sparingly soluble in water; soluble in ethanol (~750 g/l) TS; slightly soluble in ether R. | Melting Point |
181-183 °C |
| Formula | C15H21N3O2•C7H6O3 | Boiling Point | 393.5 °C at 760 mmHg |
| Molecular Weight | 413.473 | Flash Point | 191.8 °C |
| Transport Information | UN 1544 6 | Appearance | Colourless crystals; odourless. |
| Safety | 25-45 | Risk Codes | 26/28 |
| Molecular Structure |
|
Hazard Symbols |
 T+
|
| Synonyms |
Eserinesalicylatesalt;Physostigminesalicylate |
PHYSOSTIGMINE SALICYLATE (1:1) Chemical Properties
IUPAC Name: [(3aR,8bS)-3,4,8b-Trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate ; 2-Hydroxybenzoic acid
Synonyms : Physostigmine salicylate ; Physostigmine salicylate salt ; 2-Hydroxy-,compd.with (3as-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-benzoicaci ; Ar-44 ; Physostigmine,[salicylate(1:1)] ; Physostigmine,salicylate(1:1) ; Physostolsalicylate ; Salicylicacid,compd.with physostigmine(1:1)
Product Categories: Alkaloids;Biochemistry;Indole Alkaloids
CAS NO: 57-64-7
Molecular Formula: C22H27N3O5
Molecular Weight: 413.47
Molecular Structure: 
EINECS: 200-343-8
Mol File: 57-64-7.mol
Merck : 7384
Flash Point: 191.8 °C
Enthalpy of Vaporization: 64.34 kJ/mol
Boiling Point: 393.5 °C at 760 mmHg
Melting point: 181-183 °C
Vapour Pressure: 2.12E-06 mmHg at 25°C
Form: Physostigmine salicylate (1:1) (CAS NO.57-64-7) is solid .
PHYSOSTIGMINE SALICYLATE (1:1) Uses
Physostigmine salicylate (1:1) (CAS NO.57-64-7) is used as bulk pharmaceuticals (parasympathomimetic, cholinergic, ophthalmic, anti-Alzheimer).
PHYSOSTIGMINE SALICYLATE (1:1) Toxicity Data With Reference
| 1. | ivn-man TDLo:14 µg/kg:CVS,GIT | JCLPDE Journal of Clinical Psychiatry. 46 (1985),446. | ||
| 2. | scu-rat LD50:2 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 25 (1973),569. | ||
| 3. | ims-rat LD50:1280 µg/kg | DCTODJ Drug and Chemical Toxicology. 7 (1984),507. | ||
| 4. | orl-mus LD50:2500 µg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 81 (1950),726. | ||
| 5. | ipr-mus LD50:640 µg/kg | TXAPA9 Toxicology and Applied Pharmacology. 28 (1974),227. | ||
| 6. | scu-mus LD50:800 µg/kg | JPPMAB Journal of Pharmacy and Pharmacology. 34 (1982),603. | ||
| 7. | ivn-mus LD50:310 µg/kg | TXAPA9 Toxicology and Applied Pharmacology. 20 (1971),474. | ||
| 8. | scu-dog LDLo:1200 µg/kg | NTIS** National Technical Information Service. (Springfield, VA 22161) (Formerly U.S. Clearinghouse for Scientific and Technical Information) PB158-508 . | ||
| 9. | scu-cat LDLo:800 µg/kg | NTIS** National Technical Information Service. (Springfield, VA 22161) (Formerly U.S. Clearinghouse for Scientific and Technical Information) PB158-508 . | ||
| 10. | scu |
PHYSOSTIGMINE SALICYLATE (1:1) Consensus Reports
EPA Extremely Hazardous Substances List. Reported in EPA TSCA Inventory.
PHYSOSTIGMINE SALICYLATE (1:1) Safety Profile
Poison by ingestion, subcutaneous, intramuscular, intravenous, and intraperitoneal routes. Human systemic effects: arrhythmias, nausea or vomiting. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx. See also PHYSOSTIGMINE.
Hazard Codes
T+
Risk Statements 26/28
R26/28:Very toxic by inhalation and if swallowed.
Safety Statements 25-45
S25:Avoid contact with eyes.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR UN 1544 6.1/PG 1
WGK Germany 3
RTECS TJ2450000
HazardClass 6.1(a)
PackingGroup II
PHYSOSTIGMINE SALICYLATE (1:1) Specification
1.General Description: Crystal form that turns red on exposure to heat or light.
2.Reactivity Profile: Behaves as a weak acid in solution.
3.Health Hazard : Physostigmine salicylate (1:1) (CAS NO.57-64-7) is similar to physostigmine. It is classified as super toxic. The probable oral lethal dose (humans) is less than 5 mg/kg or a taste for a 150 lb. person. It is a cholinesterase inhibitor.
4.Fire Hazard: When heated to decomposition, Physostigmine salicylate (1:1) (CAS NO.57-64-7) emits toxic fumes of nitrogen oxides.
What can I do for you?
Get Best Price
